Study highlights delays in mental health support for children and young people

Children and young people with high levels of mental health needs are struggling to receive the help they need, or to have their difficulties recognized, according to a new study.

Tris Pharma receives ex-US approvals for ADHD treatments

An estimated 129 million individuals aged five to 19, along with 366 million adults globally, are affected by ADHD. Credit: MGARCIA_CREATIVE/Shutterstock. Tris Pharma has received

November 20, 2024

AriBio licenses Alzheimer’s pill in China for up to $770m – Pharmaceutical Technology

Share this article AR1001 is an oral tablet that inhibits neuronal death and restores synaptic plasticity. Image credit: Shutterstock/mapush. AriBio has signed off on exclusive

March 25, 2024

Amgen closes $28B Horizon acquisition a month after FTC battle ended

Amgen has sealed its high-profile $27.8 billion pursuit of Horizon Therapeutics, closing the deal after a lengthy 10-month acquisition process in which the Federal Trade

October 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.